![]() |
市場調查報告書
商品編碼
1279647
2022-2029年全球精準醫療市場規模研究和預測,按技術和應用及區域分析Global Precision Medicine Market Size study & Forecast, by Technology by Application, and Regional Analysis, 2022-2029 |
精準醫學是一門新興的科學,它將治療決定集中在病人的基因特徵、生活方式和環境上。精準醫學在治療癌症方面的成功促使了它的普及。它使醫學專家和研究人員能夠預測每一種具體疾病的更精確的治療和預防措施。精準醫學的關注重點在於健康身體細胞變成癌細胞的突變,通常被稱為個性化醫學或定制醫學。與傳統藥物相比,精準醫學在癌症靶向治療中的應用提供了更少的不良反應,促進了更快的康復。由於中樞神經系統疾病發病率的增加和癌症生物學的進步等因素,精準醫學市場正在擴大。
由於包括癌症和不常見疾病在內的嚴重疾病的患病率上升,該領域已經創建了幾種基因療法,診斷和藥物。根據國際癌症研究機構(IARC)的估計,在全球範圍內,2018年有1700萬個新的癌症病例和950萬個癌症相關的死亡病例。據估計,到2040年,全世界的癌症負擔將增加到2750萬新病例。此外,細胞生物學和技術的發展正在推動審查中的行業的發展。例如,2021年5月,AdventHealth推出了一個數據驅動的精準醫療計劃,作為其基因組學計劃擴展的一部分。這項計劃組織和整合縱向病人數據與分子測試數據,從而建立一個數據集和疾病網路模型,幫助醫療系統更好地預測疾病的發生以及它們對治療的反應。因此,這些發展正在推動增長。此外,精準醫療的技術進步和與精準醫療相關的投資增長正在為市場創造一個有利可圖的增長。然而,精準醫療發展的高成本阻礙了市場增長。
全球精準醫療市場研究的主要地區包括亞太地區、北美、歐洲、拉丁美洲和世界其他地區。由於品牌技術的主導地位和該地區日益增長的疾病流行率,北美在收入方面主導了市場。而亞太地區在預測期內預計將以最高的複合年增長率增長,原因是老年病的增加、藥品開發合作數量的增加、主要參與者的地理擴張以及政府和非營利組織在市場空間的積極參與等因素。
該研究的目的是定義近年來不同市場區隔和國家的市場規模,並預測未來幾年的價值。該報告旨在涵蓋參與研究的國家/地區的該行業的定性和定量方面。
該報告還提供了關於關鍵方面的詳細資訊,如驅動因素和挑戰,這將確定市場的未來增長。此外,它還涵蓋了微觀市場的潛在機會,供利益相關者投資,以及對競爭格局和主要參與者的技術產品的詳細分析。 .
Global Precision Medicine Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Precision medicine is an emerging science that focuses treatment decisions on a patient's genetic profile, way of life, and environment. The success of precision medicine in treating cancer has led to an increase in its popularity. It enables medical professionals and researchers to forecast more precise treatment and prevention measures for every specific disease. Precision medicine, which focuses on the mutations that turn healthy bodily cells into cancerous ones, is often referred to as personalized medicine or tailored medicine. In comparison to conventional medications, the use of precision medicine in targeted cancer treatment offers fewer adverse effects and promotes faster recovery. The Precision Medicine market is expanding because of factors such as increasing incidence of central nerves system disorders and advancement in cancer biology.
Several gene therapies, diagnostics, and medications have been created in this field as a result of the rise in the prevalence of serious illnesses including cancer and uncommon diseases. According to estimates from the International Agency for Research on Cancer (IARC), globally, there were 17.0 million new instances of cancer and 9.5 million cancer-related deaths in 2018. It is estimated to increase the worldwide burden of cancer to 27.5 million new cases by 2040. Furthermore, the development of the industry under review is being fueled by developments in cell biology and technology. For instance, in May 2021, AdventHealth launched a data-driven precision medicine initiative as part of the expansion of its genomics programme. This initiative organize and integrate longitudinal patient data with molecular testing data, resulting in the creation of a dataset and disease network models that will aid the healthcare system in better anticipating the onset of diseases and how they will respond to treatments. Thus, these developments are fueling the growth. In addition, higher technological advancements of precision medicine and growing investments associated with precision medicine is creating a lucrative growth to the market. However, high cost for precision medicine development halt market growth.
The key regions considered for the Global Precision Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded Technologies and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Technology offerings of key players. The detailed segments and sub-segment of the market are explained below.
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable